Back

Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-IT

26 August 2023 (09:07 - 09:26)
Organised by: Logo
Congress Presentation Part of: Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Deepak Bhatt

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on cardiovascular residual risk management: role of triglycerides and remnant cholesterol
Professor J. Jukema (Leiden, NL)
Slides Video
Presentation thumbnail
Independent causal effect of remnant cholesterol on atherosclerotic cardiovascular outcomes: a Mendelian randomization study
Ms K. Grzelakowska (Bydgoszcz, PL)
Abstract Slides Video
Presentation thumbnail
Low HDL cholesterol and hyperglicemia are metabolic syndrome components associated with plaque progression in patients with chronic coronary syndrome: a PARADIGM study
Doctor D. Neglia (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 09:07 CET
You may be interested in
thumbnail
Congress Presentation
Understanding the clinical benefit of icosapent ethyl: insights from REDUCE-IT
thumbnail
Congress Presentation
Effects of icosapent ethyl on risk and duration of hospitalizations and death in REDUCE-IT
thumbnail
Congress Presentation
Managing a patient with residual risk: applying recent evidence with EPA to practice

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources